Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour

Psychopharmacology (Berl). 2005 Sep;181(2):289-98. doi: 10.1007/s00213-005-2233-3. Epub 2005 Oct 14.

Abstract

Rationale: Temporal differentiation refers to animals' ability to regulate their behaviour during an ongoing interval. Striatal dopaminergic mechanisms are purported to be involved in temporal differentiation, and recent evidence also implicates 5-hydroxytryptaminergic (5-HTergic) mechanisms, possibly mediated by 5-HT(2A) receptors. There is evidence that 5-HT(3) receptors contribute to the regulation of dopamine release in the basal ganglia; however, it is not known whether 5-HT(3) receptor stimulation can influence temporal differentiation.

Objective: We examined the effects of a selective 5-HT(3) receptor agonist m-CPBG, a mixed 5-HT(2A/3) receptor agonist quipazine, and selective 5-HT(3) and 5-HT(2A) receptor antagonists (MDL-72222 and ketanserin, respectively) on temporal differentiation in a free-operant psychophysical procedure.

Methods: Twenty-four rats were trained to respond on two levers (A and B) under a free-operant psychophysical schedule, in which sucrose reinforcement (0.6 M: , 50 microl) was provided intermittently for responding on A during the first half and on B during the second half of 50-s trials. Logistic psychometric functions were fitted to the relative response rate data [percent responding on B (%B) vs time from trial onset (t)], and quantitative indices of timing performance [T (50) (value of t corresponding to %B=50), Weber fraction, and mean time of switching from A to B, S (50)] were derived.

Results: Quipazine (0.5, 1, and 2 mg kg(-1)) altered timing performance, dose-dependently reducing T (50) and S (50); m-CPBG (2.5, 5, and 10 mg kg(-1)) had no significant effect. The effect of quipazine was antagonized by ketanserin (2 mg kg(-1)), but not by MDL-72222 (1 mg kg(-1)).

Conclusions: The present results provide no evidence for the involvement of 5-HT(3) receptors in temporal differentiation and indicate that the effect of quipazine on performance was mediated by 5-HT(2A) receptor stimulation. The results are consistent with previous evidence for the involvement of 5-HT(2A) receptors in interval timing behaviour.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biguanides / administration & dosage
  • Biguanides / pharmacology*
  • Conditioning, Operant / drug effects
  • Dose-Response Relationship, Drug
  • Female
  • Injections, Intraperitoneal
  • Injections, Subcutaneous
  • Ketanserin / administration & dosage
  • Ketanserin / pharmacology
  • Psychometrics / methods
  • Quipazine / administration & dosage
  • Quipazine / pharmacology*
  • Rats
  • Rats, Wistar
  • Receptor, Serotonin, 5-HT2A / physiology
  • Receptors, Serotonin, 5-HT3 / physiology
  • Serotonin 5-HT2 Receptor Agonists
  • Serotonin 5-HT2 Receptor Antagonists
  • Serotonin 5-HT3 Receptor Agonists
  • Serotonin 5-HT3 Receptor Antagonists
  • Serotonin Antagonists / pharmacology
  • Serotonin Receptor Agonists / administration & dosage
  • Serotonin Receptor Agonists / pharmacology
  • Task Performance and Analysis*
  • Time Perception / drug effects*
  • Time Perception / physiology
  • Tropanes / administration & dosage
  • Tropanes / pharmacology

Substances

  • Biguanides
  • Receptor, Serotonin, 5-HT2A
  • Receptors, Serotonin, 5-HT3
  • Serotonin 5-HT2 Receptor Agonists
  • Serotonin 5-HT2 Receptor Antagonists
  • Serotonin 5-HT3 Receptor Agonists
  • Serotonin 5-HT3 Receptor Antagonists
  • Serotonin Antagonists
  • Serotonin Receptor Agonists
  • Tropanes
  • Quipazine
  • 1-(3-chlorophenyl)biguanide
  • Ketanserin
  • bemesetron